Working… Menu

Dolutegravir Plus 2 NRTIs, in Treatment-Naïve HIV-2 Infected Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03224338
Recruitment Status : Completed
First Posted : July 21, 2017
Last Update Posted : September 2, 2019
Information provided by (Responsible Party):
Blueclinical, Ltd.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 2, 2019
Actual Study Completion Date : July 2, 2019